Neomycin Sulphate Price Trend and Forecast

Regional Price Overview

Get the latest insights on price movement and trend analysis of Neomycin Sulphate in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).

Neomycin Sulphate Price Trend for the October - December of 2023


The rift between government policies and manufacturers' profit was evident in the neomycin sulphate price trend. In the last quarter of 2023, pharmaceutical industries decided to raise the quotations of medicines as the low import of raw materials from China and expansion of the consumer base increased the producers' cost of manufacturing.

Neomycin Sulphate Price Chart

Neomycin Sulphate Price Trends

Please Login or Subscribe to Access the Neomycin Sulphate Price Chart Data

But this upwards journey of neomycin sulphate was halted when the Indian government announced a reduction in the cost of medicines in order to keep them consumer friendly, and thus, as a result, the neomycin sulphate price trend remained uncertain throughout the quarter.


As the cost of raw materials elevated in the European countries on account of ongoing tensions between Israel and Hamas and the consequences of the ban on Russian imports, the pharmaceutical industries found it difficult to sustain their production activities.

The European Federation thus proposed innovations in the medicinal sector to curb this problem, but according to EPFIA, the proposal failed to measure the current dynamics of the European Pharmaceutical industries and the expenditure it will require to process the same. These struggling conditions and rising inflationary pressure and rates of interest led to oscillations in the neomycin sulphate price trend.

North America

The US government's Inflation Reduction Act halted the thoughtless increase in the price of pharmaceuticals. This act aims to lower the excessive cap on pharmaceuticals like neomycin sulphate, but it will take some time to show any results. A similar scenario of the pharmaceutical industries was observed in Asian countries, too.

However, the demand from the consumer sector and the rising cost of raw materials created an opportunity for the price of neomycin sulphate to increase, forcing the manufacturing sector to increase its price quote.

Analyst Insight

According to Procurement Resource, the price trend of Neomycin Sulphate are expected to be dictated by the demand from the downstream industries and the future of regional struggles between the government and pharmaceutical industries.

Neomycin Sulphate Price Trend for the July-September of 2023


Neomycin Sulphate began its market run with a major slump at the beginning of the third quarter in the Asian markets, particularly China. The veterinary antibiotic drug was experiencing a depressing phase since the production facilities were struggling for a long time in China.

Supplies were long cut short, which made the consuming pharma and biotech sectors shift to other alternative options. So, the neomycin sulphate price index noted a steep fall at the beginning of the first month of the quarter. Even though the following months witnessed some rebound in the neomycin sulphate price trend, the general market outlook was regressive. Overall, low-wavering price trend were observed during the said period.


The European market trend for neomycin sulphate were no different than the Asian trend during the said period of Q3’23, primarily because many European markets are dependent on Asian exports for veterinary drugs like neomycin sulphate. Apart from this, the gradually easing inflationary pressure also took away the upstream cost support. The demand front was also not exciting for neomycin sulphate. So, the general market sentiments remained muted throughout the quarter.

North America

Neomycin Sulphate trade in the American market painted no different picture than the global trend. The price trend were found to be struggling here, too, as the economic situation in the region was still unstable. Overall, a poor market outlook was observed.

Analyst Insight

According to Procurement Resource, Neomycin Sulphate price analysis offers positive forecasts for the coming months since the depreciated market will look for normalization.

Neomycin Sulphate Price Trend for the First Half of 2023


The prices of neomycin sulphate witnessed a significant incline in the first quarter of 2023 as positive demand from the downstream pharmaceutical and healthcare industries drove the market dynamics.

The bullish trend was also a result of the enhanced interest of international customers, and after the long stretch of covid and the holiday season in China, the consumption, as well as production rates, gained momentum, resulting in northwards movement of the neomycin sulphate prices.

However, the second quarter did not follow this path, and from late April, the price trend of neomycin sulphate began to decline. This quarter was further affected by a notable reduction in consumption and a slowing down of manufacturing activities.


The first quarter of 2023 maintained a consistent rise in the prices of neomycin sulphate as the rates of inflation declined along with the cost of energy production. This further improved the trading activities of neomycin sulphate in the region and thus helped the neomycin sulphate prices to move in a positive direction.

Even in the first two months of the second quarter, the limited level of inventories, consistent demand, and slow supply of the products supported the rising cost of neomycin sulphate prices. But in the last month, the rates of inflation started to surge, which in turn caused the cost of energy and interest rates charged by European banks to hike. Further, the depreciation of the Euro in comparison to the US dollar ultimately led to the fall in the price trend of neomycin sulphate.

North America

In the first quarter, the neomycin sulphate market demonstrated strong market movement with a stable rise in the number of orders from the downstream industries, and the price trend of neomycin sulphate inclined. In addition to this, the expensive imports from Asian countries also supported the rise in the price trend.

In the second quarter, many manufacturing units reduced their production activities, putting pressure on the existing level of inventories and supply chains while the demand from the end-user industries remained high, causing the price trend to further incline. But in the last month of the second quarter, the rise in interest rates and overall inflation in North America hampered the growth of neomycin sulphate prices.

Analyst Insight

According to Procurement Resource, the price trend of Neomycin Sulphate is expected to oscillate in the upcoming quarters as the demand from the downstream industries seems to be sliding amid the weak global economic conditions.

Procurement Resource provides latest prices of Neomycin Sulphate. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.

Please Login or Subscribe to explore our dashboard.


Neomycin Sulphate is an antibiotic that is frequently used in veterinary applications that belongs to the aminoglycoside class of antibiotics that is effective in several bacterial infections. It is often used in several formulations such as creams and ointments. It also plays a significant role in the field of biotechnology for cell culture and genetic engineering purposes. This compound helps to study and manipulate gene expression in cells.

Product Details

Report Features Details
Product Name Neomycin Sulphate
Chemical formula C23H46N6O13.H2SO4
Industrial Uses Pharmaceutical Manufacturing, Biotechnology, Agriculture, Fisheries
CAS Number 1405-10-3
Molecular weight 712.72 g/mol
HS Code 29419050
Supplier Database McKesson Corporation, Pfizer Inc, Bausch & Lomb, Perrigo Company, Medimetriks Pharmaceutical, Xgen Pharmaceuticals
Region/Countries Covered Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Iran, Thailand, South Korea, Iraq, Saudi Arabia, Malaysia, Nepal, Taiwan, Sri Lanka, UAE, Israel, Hongkong, Singapore, Oman, Kuwait, Qatar, Australia, and New Zealand

Europe: Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece

North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru

Africa: South Africa, Nigeria, Egypt, Algeria, Morocco
Currency US$ (Data can also be provided in local currency)
Supplier Database Availability Yes
Customization Scope The report can be customized as per the requirements of  the customer
Post-Sale Analyst Support 360-degree analyst support after report delivery

Note: Our supplier search experts can assist your procurement teams in compiling and validating a list of suppliers indicating they have products, services, and capabilities that meet your company's needs.


The displayed pricing data is derived through weighted average purchase price, including contract and spot transactions at the specified locations unless otherwise stated. The information provided comes from the compilation and processing of commercial data officially reported for each nation (i.e. government agencies, external trade bodies, and industry publications).

Assistance from Experts

Procurement Resource is a one-stop solution for businesses aiming at the best industry insights and market evaluation in the arena of procurement. Our team of market leaders covers all the facets of procurement strategies with its holistic industry reports, extensive production cost and pre-feasibility insights, and price trends dynamics impacting the cost trajectories of the plethora of products encompassing various industries. With the best analysis of the market trends and comprehensive consulting in light of the best strategic footstep, Procurement Resource got all that it takes.

Client's Satisfaction

Procurement Resource has made a mark for itself in terms of its rigorous assistance to its clientele. Our experienced panel of experts leave no stone unturned in ensuring the expertise at every step of our clients' strategic procurement journey. Our prompt assistance, prudential analysis, and pragmatic tactics considering the best procurement move for industries are all that sets us apart. We at Procurement Resource value our clients, which our clients vouch for.

Assured Quality

Expertise, judiciousness, and expedience are the crucial aspects of our modus operandi at Procurement Resource. Quality is non-negotiable, and we don't compromise on that. Our best-in-class solutions, elaborative consulting substantiated by exhaustive evaluation, and fool-proof reports have led us to come this far, making us the ‘numero uno' in the domain of procurement. Be it exclusive qualitative research or assiduous quantitative research methodologies, our high quality of work is what our clients swear by.

Table Of Contents

Our Clients


Get in Touch With Us


Phone:+1 307 363 1045


Phone: +91 1203185500


Phone: +44 7537 132103



Get latest News About Procurement Resource
Subscribe for news

This site uses cookies (including third-party cookies) to record user’s preferences. See our Privacy PolicyFor more.